Masaki Fujita

6PUBLICATIONS
38CO-AUTHORS
Major global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMedical bacteriologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 08, 2026
Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema.

|May 26, 2026
Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in patients with locally advanced NSCLC.

|Dec 04, 2025
Early Pseudoprogression Mimicking Pneumonitis After Tarlatamab Therapy: A Case Suggestive of Immune Cell-Associated Respiratory Syndrome (ICARS).

Natsumi Kushima, Toyoshi Yanagihara, Takato Ikeda

|Apr 25, 2025
Pulmonary Nontuberculous Mycobacteria Infection in Bronchiectasis: A Narrative Review of Current Status and Future.

Masaki Fujita

|Oct 11, 2024
Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.

Hidetoshi Hayashi, Makoto Nishio, Hiroaki Akamatsu

|Mar 29, 2023
TNFR1 Mediated Apoptosis Is Protective against Mycobacterium avium in Mice.

Yuki Shundo, Rintaro On, Takemasa Matsumoto

Pageof 1

Frequent Collaborators

2 joint publications

Hiroaki Akamatsu

2 joint publications

Akihiko Gemma

2 joint publications

Tetsuya Mitsudomi

2 joint publications

Atsuto Mouri